| Peter Van Buren, | |
|
62 Tilley Dr, South Burlington, VT 05403-4407 | |
| (802) 847-4600 | |
| Not Available |
| Full Name | Peter Van Buren |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 37 Years |
| Location | 62 Tilley Dr, South Burlington, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104912310 | NPI | - | NPPES |
| OVNO408 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Champlain Valley Physicians Hospital Medical Ctr | Plattsburgh, NY | Hospital |
| Northwestern Medical Center Inc | Saint albans, VT | Hospital |
| Porter Hospital, Inc | Middlebury, VT | Hospital |
| Copley Hospital | Morrisville, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwestern Medical Center Inc | 5496714313 | 86 |
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Proteins produced by cancer cells are among the common targets for anticancer agents, and thanks to efforts in proteomics and cancer genomics, the number of potential protein targets is increasing exponentially.
The effective design and analysis of experiments in biology are critical to success, yet graduate students in biological and medical sciences typically receive very little formal training in these steps.
Today's younger generation may reckon that "ne'er the twain shall meet" where technology and their elders are concerned. However, ongoing research by Abby King, PhD, professor of health research and policy and of medicine at the Stanford Prevention Research Center, appears to be gradually dispelling that notion.
In its continuing initiatives around Doing What's Right, SC Johnson, A Family Company, recently announced its first commitment as part of its involvement in the Clinton Global Initiative (CGI). Founded by former President Bill Clinton in 2005, CGI brings world leaders from a variety of backgrounds together to create partnerships that result in innovative and measurable solutions to some of the world's most pressing challenges.
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
› Verified 7 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Proteins produced by cancer cells are among the common targets for anticancer agents, and thanks to efforts in proteomics and cancer genomics, the number of potential protein targets is increasing exponentially.
The effective design and analysis of experiments in biology are critical to success, yet graduate students in biological and medical sciences typically receive very little formal training in these steps.
Today's younger generation may reckon that "ne'er the twain shall meet" where technology and their elders are concerned. However, ongoing research by Abby King, PhD, professor of health research and policy and of medicine at the Stanford Prevention Research Center, appears to be gradually dispelling that notion.
In its continuing initiatives around Doing What's Right, SC Johnson, A Family Company, recently announced its first commitment as part of its involvement in the Clinton Global Initiative (CGI). Founded by former President Bill Clinton in 2005, CGI brings world leaders from a variety of backgrounds together to create partnerships that result in innovative and measurable solutions to some of the world's most pressing challenges.
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
› Verified 7 days ago
| Entity Name | Northwestern Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538293469 PECOS PAC ID: 5496714313 Enrollment ID: O20081114000535 |
News Archive
Proteins produced by cancer cells are among the common targets for anticancer agents, and thanks to efforts in proteomics and cancer genomics, the number of potential protein targets is increasing exponentially.
The effective design and analysis of experiments in biology are critical to success, yet graduate students in biological and medical sciences typically receive very little formal training in these steps.
Today's younger generation may reckon that "ne'er the twain shall meet" where technology and their elders are concerned. However, ongoing research by Abby King, PhD, professor of health research and policy and of medicine at the Stanford Prevention Research Center, appears to be gradually dispelling that notion.
In its continuing initiatives around Doing What's Right, SC Johnson, A Family Company, recently announced its first commitment as part of its involvement in the Clinton Global Initiative (CGI). Founded by former President Bill Clinton in 2005, CGI brings world leaders from a variety of backgrounds together to create partnerships that result in innovative and measurable solutions to some of the world's most pressing challenges.
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Van Buren, 500 S Willard St, Burlington, VT 05401-4005 Ph: () - | Peter Van Buren, 62 Tilley Dr, South Burlington, VT 05403-4407 Ph: (802) 847-4600 |
News Archive
Proteins produced by cancer cells are among the common targets for anticancer agents, and thanks to efforts in proteomics and cancer genomics, the number of potential protein targets is increasing exponentially.
The effective design and analysis of experiments in biology are critical to success, yet graduate students in biological and medical sciences typically receive very little formal training in these steps.
Today's younger generation may reckon that "ne'er the twain shall meet" where technology and their elders are concerned. However, ongoing research by Abby King, PhD, professor of health research and policy and of medicine at the Stanford Prevention Research Center, appears to be gradually dispelling that notion.
In its continuing initiatives around Doing What's Right, SC Johnson, A Family Company, recently announced its first commitment as part of its involvement in the Clinton Global Initiative (CGI). Founded by former President Bill Clinton in 2005, CGI brings world leaders from a variety of backgrounds together to create partnerships that result in innovative and measurable solutions to some of the world's most pressing challenges.
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
› Verified 7 days ago
Dr. Michael Scollins, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Timber Ln, South Burlington, VT 05403 Phone: 802-847-4714 Fax: 802-847-6333 | |
Dr. Matthew Philip Gilbert, DO, MPH Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Timber Ln, South Burlington, VT 05403 Phone: 802-847-4576 | |
Jennifer J Kelly, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 62 Tilley Dr Ste 202, South Burlington, VT 05403 Phone: 802-847-4576 Fax: 802-847-4967 | |
Dr. Jennifer Plante Gilwee, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Timber Ln, South Burlington, VT 05403 Phone: 802-847-4714 | |
Dr. David Ziegelman, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1 Timber Lane, South Burlington, VT 05403 Phone: 802-847-4714 Fax: 802-847-6333 | |
Dr. Theresa Maria Collier, D.O. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 62 Tilley Dr Ste 202, South Burlington, VT 05403 Phone: 802-847-4576 |